The determination of a safe and effective rate at which intravenous immunoglobulin (IVIG) is administered is a critical aspect of patient care. A tool designed to assist in this determination takes into account factors such as patient weight, the concentration of the IVIG product, and the patient’s medical history to calculate the optimal rate. As an example, the starting infusion rate might be lower for individuals with a history of migraine or renal insufficiency.
Precise calculation of the administration rate is essential to minimize the risk of adverse reactions and ensure optimal therapeutic effect. Historically, these calculations were performed manually, increasing the potential for error. The application of a dedicated calculation method enhances patient safety by providing a standardized and reliable approach to infusion rate determination. Furthermore, appropriate administration contributes to efficient utilization of healthcare resources by preventing complications that may necessitate additional interventions.